ONYDA XR

Indicated For

Attention Deficit Hyperactivity Disorder (ADHD)

About This Medication

# Tris Savings Card Patient Guide: How to Get ONYDA XR at Low or No Cost ONYDA XR (clonidine hydrochloride) is an extended-release oral suspension approved for treating attention deficit hyperactivity disorder (ADHD) in children aged 6 years and older, either alone or with other ADHD medications.[1][6] The **Tris Savings Card** from Tris Pharma, Inc. helps **eligible patients pay just $25 per prescription**, making this important ADHD treatment more affordable.[2] ## About ONYDA XR **ONYDA XR** is a once-daily, non-stimulant medication that comes as a liquid suspension, making it easier for children who struggle with pills.[1][6] It works by affecting certain chemicals in the brain to improve focus, reduce impulsivity, and control hyperactivity. Unlike stimulant ADHD drugs, ONYDA XR is not a controlled substance, which may be preferable for some families concerned about abuse potential.[8] It's specifically studied for kids 6 and up—safety and effectiveness aren't established for younger children.[1][6] Common side effects include sleepiness, headache, and stomach upset, but always discuss risks with your doctor. ONYDA XR can be used alone or added to stimulants for better control of ADHD symptoms.[6] If your child has been diagnosed with ADHD, talk to their healthcare provider about whether ONYDA XR fits their treatment plan. ## Who Qualifies for the Tris Savings Card? This program is designed for **commercially insured patients** who need help with out-of-pocket costs for ONYDA XR or other Tris ADHD products like DYANAVEL XR, QUILLIVANT XR, or QUILLICHEW ER.[2] Key eligibility points: - You must have **commercial (private) insurance**—not government programs.[2] - Valid U.S. prescription for ONYDA XR from a licensed provider.[2] - Patient must be within the approved age range (6+ for ONYDA XR).[1][2] - U.S. resident (including territories).[2] **Important exclusions**: Not valid for Medicare, Medicaid, TriCare, Indian Health Service, Puerto Rico Government Health Insurance, or any federal/state prescription programs.[2] It's also not for cash-paying patients without commercial insurance or those using other discounts.[2] No specific income thresholds are required, making it accessible regardless of earnings—as long as you have qualifying insurance.[2] ## Income Eligibility Breakdown The Tris Savings Card **does not use income thresholds**. Qualification hinges on insurance type and prescription validity, not household income.[2] This differs from traditional patient assistance programs that cap eligibility at 400% of the federal poverty level (FPL).[7] Here's a simple table comparing it: | Criterion | Tris Savings Card Requirement | Traditional PAPs (e.g., via NowPatient)[7] | |------------------------|------------------------------------------------|--------------------------------------------| | **Income Limit** | None | Often ≤400% FPL | | **Insurance** | Commercial only (excludes govt programs) | May allow Medicare/Medicaid | | **Residency** | U.S. and territories | U.S. and territories | | **Cost Savings** | $25 per Rx (max limits apply) | Free or very low cost | | **Age** | Per drug PI (6+ for ONYDA XR) | Varies | This table shows why the Savings Card is ideal for insured families facing high deductibles or copays.[2] ## Insurance Requirements **Commercial insurance is required**—present your insurance card at the pharmacy.[2] The card reduces your copay to **$25 per fill**, with predictable costs even for high-deductible plans.[2] It includes eWallet functionality for easy digital use and text refill reminders.[2] **Not eligible** if on Medicare, Medicaid, etc.—check other options like state programs if excluded.[2] Verify coverage for ONYDA XR specifically, as out-of-pocket varies.[2] ## Step-by-Step Application Process Getting started is straightforward with **multiple application methods**.[1][2][4] 1. **Get your prescription**: Ask your doctor to prescribe ONYDA XR. Ensure it includes a valid prescriber ID.[5] 2. **Activate the Savings Card**: - Visit the activation site (search 'Tris Savings Card activation').[4] - Fill in required info (*) like name, email, and verify eligibility.[4] - Receive your digital eCard instantly. 3. **Or call for help**: Dial **(872) 351-5682** for assistance activating or questions.[1][2] 4. **At the pharmacy**: Show the card (digital or printed) when filling. Pharmacist applies the $25 copay.[2][5] 5. **Refills**: Use the card each time—texts remind you.[2] ePrescribe to Perigon Pharmacy 360 for free shipping or pickup if needed.[2] No lengthy forms or documents typically required beyond prescription and insurance proof at fill.[2][5] ## Timeline and Delivery **Instant activation** online—use right away.[4] No fixed processing time; savings apply **at the time of dispensing**.[2] Medication is **shipped to patient** or picked up locally via Perigon Pharmacy, with free shipping guaranteed availability.[2] Refills follow the same quick process with reminders.[2] Expect standard pharmacy timelines (1-3 days for fills). ## Alternatives if Denied or Ineligible If denied (e.g., government insurance): - **Generic clonidine**: Cheaper immediate-release option; ask your doctor.[8] - **Other PAPs**: Check NowPatient or Patient Advocate Foundation for income-based aid (e.g., ≤400% FPL, Medicare OK).[7] - **WellRx or GoodRx**: Discount cards for cash pay.[8] - **Manufacturer alternatives**: Tris other products if switching ADHD meds.[2] - **State assistance**: Varies by location. Contact **(872) 351-5682** for guidance.[2] ## Disclaimer This guide is for informational purposes based on available program details as of latest updates.[1][2] Eligibility, terms, and savings can change—**always verify with Tris Pharma at (872) 351-5682 or your pharmacist**.[2] Not valid where prohibited; max savings limits apply; patient pays excess.[2] Consult your doctor before starting ONYDA XR. Tris Savings Card not transferable or combinable with other offers.[2] Not medical or financial advice.

Program information last verified: March 30, 2026